Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00345553 · ClinicalTrials.gov registry record
Biliary Atresia Study in Infants and Children
A clinical trial of Biliary Atresia, sponsored by Arbor Research Collaborative for Health.
- Recruiting
- Registry status
- 1,265
- Enrollment target
- 16
- Study locations
NCT00345553: Recruiting study of Biliary Atresia, sponsored by Arbor Research Collaborative for Health.
NCT00345553 is a study of Biliary Atresia that is actively recruiting participants, run by Arbor Research Collaborative for Health. The registered enrollment target is 1,265 participants, above the 394-participant average among 7 other Biliary Atresia trials with a reported enrollment target (221% higher). The trial reports 16 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00345553, a study of Biliary Atresia, is actively recruiting participants, sponsored by Arbor Research Collaborative for Health.
- RECRUITING
- Registry status
- 1,265 participants
- Enrollment target
- 16
- Study locations
Study Summary
Little is known about the factors that cause biliary atresia nor the factors that influence disease progression. The purpose of this study is to collect the pertinent clinical information, genetic material and body fluid samples to enable investigators to address the following aims: To identify the gene or genes implicated in the etiology of BA; To characterize the natural history of the older, non-transplanted child with BA.
Primary Outcome
The genetics of BA may be investigated on two levels. The first is to identify a group of patients whose etiology is a result of a genetic defect and the second is to examine the influence of genetics on disease acquisition.
Conditions Studied
Study Locations (16)
California
- Children's Hospital of Los Angeles - Los Angeles
- University of California at San Francisco - San Francisco
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
- UPMC Children's Hospital of Pittsburgh - Pittsburgh
Colorado
- Children's Hospital Colorado - Aurora
Georgia
- Children's Healthcare of Atlanta - Emory University - Atlanta
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
Indiana
- Riley Children's Hospital - Indianapolis
Maryland
- Johns Hopkins School of Medicine - Baltimore
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,265 participants |
| Start Date | 2006-05-16 |
| Est. Completion | 2029-05-31 |
What NCT00345553 shows while recruiting
NCT00345553 is an observational study that tracks outcomes without assigning an intervention. Its 1,265 participants enrollment target places it among the larger protocols in the corpus, above the 394-participant average among 7 other Biliary Atresia trials with a reported enrollment target (221% higher).
The record links to 1 condition, with Biliary Atresia appearing as the primary indexed condition, and to 0 interventions.
NCT00345553 lists 16 locations in 14 states (California, Pennsylvania, Colorado).
Frequently Asked Questions
What is clinical trial NCT00345553 about?
NCT00345553 is a clinical study titled "Biliary Atresia Study in Infants and Children". Little is known about the factors that cause biliary atresia nor the factors that influence disease progression. The purpose of this study is to collect the pertinent clinical information, genetic material and body fluid samples to enable investigators to address the following aims: To identify the ...
What is the current status of trial NCT00345553?
This trial is currently recruiting. The enrollment target is 1,265 participants. The study started on 2006-05-16. Estimated completion is 2029-05-31.
What conditions does trial NCT00345553 study?
This clinical trial studies the following conditions: Biliary Atresia.
Who is sponsoring clinical trial NCT00345553?
This trial is sponsored by Arbor Research Collaborative for Health, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00345553 being conducted?
This trial has 16 study locations across California, Colorado, Georgia, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Biliary Atresia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mapping Disease Pathways for Biliary Atresia
RECRUITING
-
Biliary Atresia Research Network Northeast
RECRUITING
-
Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
RECRUITING · Phase 1
-
A Prospective Database of Infants With Cholestasis
RECRUITING
-
The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis
RECRUITING · Early Phase 1
-
Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)
ACTIVE NOT RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06119581 · 1,264 participants · Phase 3
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- NCT06790641 · 1,270 participants · NA
Pathways to Perinatal Mental Health Equity
- NCT06876246 · 1,270 participants · NA
SBIR/ STTR Family Check-up Online
- NCT06712316 · 1,260 participants · Phase 2
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI